Both in Biotechnology
Exelixis vs Bio-Techne
Over the past year EXEL returned +79.4% and TECH returned +16.1%; their daily moves had a correlation of 0.01.
EXEL +79.4% TECH +16.1%Growth of $1, one year, split-adjusted
| Metric | EXEL | TECH |
|---|---|---|
| Price | $69.39 | $72.66 |
| Market cap | $16.93B | $11.41B |
| Today | +4.82% | −0.07% |
| 1 month | +19.8% | +0.4% |
| 6 months | +58.9% | +32.1% |
| Year to date | +58.3% | +23.6% |
| 1 year | +76.0% | +17.2% |
| Revenue growth (YoY) | +10.2% | +1.3% |
| Gross margin | 96.0% | 65.8% |
| Net margin | 33.1% | 17.0% |
| P/E (TTM) | 19.1× | 62.7× |
| Price / sales | 6.8× | 9.4× |
| Net cash | $892.0M | $64.7M |
| Dividend yield | — | 0.44% |
| Volatility (60d) | 27.5% | 2.5% |
| Short % of float | 11.4% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).